Jefferies Initiates Coverage On RxSight with Buy Rating, Announces Price Target of $72
Portfolio Pulse from Benzinga Newsdesk
Jefferies has initiated coverage on RxSight (NASDAQ:RXST) with a Buy rating and set a price target of $72.
October 29, 2024 | 11:51 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jefferies has initiated coverage on RxSight with a Buy rating and a price target of $72, indicating a positive outlook for the stock.
The initiation of coverage with a Buy rating and a specific price target by a reputable firm like Jefferies is likely to positively influence investor sentiment and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100